中文

山河药辅 Revenue Breakdown

Period 2026-03-31 ・ Reported 2026-04-23
ItemAmountY/Y
Revenue¥0.26B+5.5%
Gross profit¥0.08B
Operating income¥0.05B
Net income¥0.05B+1.8%
Gross margin32.3%Net margin 18.2%
Revenue Q/Q+6.1%

Revenue Segments

The filing did not disclose a revenue breakdown for this period.

Costs & Expenses

ItemAmount% of revenue
Cost of revenue¥0.18B67.7%
R&D¥0.01B4.1%
SG&A¥0.02B6.0%
Tax & other¥0.01B2.7%
Generate the full Sankey chart →

The Sankey chart shows how revenue splits into cost of revenue, R&D and SG&A, and what remains as profit — clean visuals for research decks and social posts.

Other companies

三鑫医疗深信服航天智装赛微电子赢合科技全志科技汤姆猫ST惠伦田中精机ST华铭迈克生物星徽股份

Source: Eastmoney · This page shows public filing data only, not investment advice. · Browse all companies